Clinical Trials In Nevada

Discover hundreds of clinical trials in Nevada.
Search clinical trials in Nevada by city, condition or phase.

e.g. Respiratory Diseases

Nevada•Healthy volunteers: No

Filter results

Results: 521

Study to Evaluate the Effects of Oral NMRA 335140 Versus Placebo in Participants With Major Depressive Disorder

Recruiting

Phase 3

Sponsor:

Neumora Therapeutics, Inc.

Location:

Las Vegas, Huntsville, Phoenix, Bentonvilleshow 55 more

Code:

NCT06029426

Conditions

Major Depressive Disorder

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Not accepted

Interventions

NMRA 335140

Placebo

Study of Ravulizumab in Immunoglobulin A Nephropathy (IgAN)

Recruiting

Phase 3

Sponsor:

Alexion Pharmaceuticals, Inc.

Location:

North Las Vegas, Alabaster, Phoenix, Loma Lindashow 30 more

Code:

NCT06291376

Conditions

Immunoglobulin A Nephropathy

IgAN

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Ravulizumab

Placebo

Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)

Recruiting

Phase 2

Sponsor:

National Cancer Institute (NCI)

Location:

Las Vegas, Henderson, Birmingham, Boiseshow 76 more

Code:

NCT06126276

Conditions

Malignant Female Reproductive System Neoplasm

Malignant Solid Neoplasm

Recurrent Malignant Female Reproductive System Neoplasm

Recurrent Malignant Solid Neoplasm

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Biopsy

Biospecimen Collection

Computed Tomography

Echocardiography

Magnetic Resonance Imaging

S1803, Lenalidomide +/- Daratumumab/rHuPh20 as Post-ASCT Maintenance for MM w/MRD to Direct Therapy Duration

Recruiting

Phase 3

Sponsor:

SWOG Cancer Research Network

Location:

Reno, Pahrump, Las Vegas, Hendersonshow 495 more

Code:

NCT04071457

Conditions

Multiple Myeloma

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Lenalidomide

Daratumumab/rHuPH20

Journey Study: Evaluate the Efficacy, Safety, and Tolerability of Valbenazine as Adjunctive Treatment for Schizophrenia

Recruiting

Phase 3

Sponsor:

Neurocrine Biosciences

Location:

Las Vegas, Phoenix, Rogers, Anaheimshow 36 more

Code:

NCT05110157

Conditions

Schizophrenia

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Placebo

Valbenazine

Popular cities in Nevada

Las Vegas

e.g. Respiratory Diseases

Nevada•Healthy volunteers: No

Filter results

Results: 521

Study to Evaluate the Effects of Oral NMRA 335140 Versus Placebo in Participants With Major Depressive Disorder

Recruiting

Phase 3

Sponsor:

Neumora Therapeutics, Inc.

Location:

Las Vegas, Huntsville, Phoenix, Bentonvilleshow 55 more

Code:

NCT06029426

Conditions

Major Depressive Disorder

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Not accepted

Interventions

NMRA 335140

Placebo

Study of Ravulizumab in Immunoglobulin A Nephropathy (IgAN)

Recruiting

Phase 3

Sponsor:

Alexion Pharmaceuticals, Inc.

Location:

North Las Vegas, Alabaster, Phoenix, Loma Lindashow 30 more

Code:

NCT06291376

Conditions

Immunoglobulin A Nephropathy

IgAN

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Ravulizumab

Placebo

Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)

Recruiting

Phase 2

Sponsor:

National Cancer Institute (NCI)

Location:

Las Vegas, Henderson, Birmingham, Boiseshow 76 more

Code:

NCT06126276

Conditions

Malignant Female Reproductive System Neoplasm

Malignant Solid Neoplasm

Recurrent Malignant Female Reproductive System Neoplasm

Recurrent Malignant Solid Neoplasm

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Biopsy

Biospecimen Collection

Computed Tomography

Echocardiography

Magnetic Resonance Imaging

S1803, Lenalidomide +/- Daratumumab/rHuPh20 as Post-ASCT Maintenance for MM w/MRD to Direct Therapy Duration

Recruiting

Phase 3

Sponsor:

SWOG Cancer Research Network

Location:

Reno, Pahrump, Las Vegas, Hendersonshow 495 more

Code:

NCT04071457

Conditions

Multiple Myeloma

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Lenalidomide

Daratumumab/rHuPH20

Journey Study: Evaluate the Efficacy, Safety, and Tolerability of Valbenazine as Adjunctive Treatment for Schizophrenia

Recruiting

Phase 3

Sponsor:

Neurocrine Biosciences

Location:

Las Vegas, Phoenix, Rogers, Anaheimshow 36 more

Code:

NCT05110157

Conditions

Schizophrenia

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Placebo

Valbenazine